Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis

Volume: 12, Issue: 3, Pages: 211 - 211
Published: Mar 1, 2020
Abstract
Eosinophilic esophagitis (EE) is a chronic immune/antigen-mediated esophageal inflammatory disease for which off-label topical corticosteroids (e.g., budesonide) are widely used in clinic. In general, thickening excipients are mixed with industrial products to improve the residence time of the drug on the esophageal mucosa. The compounding procedures are empirical and the composition is not supported by real physicochemical and technological...
Paper Details
Title
Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
Published Date
Mar 1, 2020
Volume
12
Issue
3
Pages
211 - 211
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.